380
Participants
Start Date
August 31, 2015
Primary Completion Date
October 27, 2016
Study Completion Date
January 9, 2017
NTX/BUP
Daily doses
NTX/PBO-B
Daily doses
PBO-N/PBO-B
Daily doses
New York State Psychiatric Institute/ Columbia University, New York
Western Psychiatric Institute and Clinic of UPMC, Pittsburgh
University Of Pennsylvania - Treatment Research Center, Philadelphia
John Hopkins University School of Medicine, Baltimore
Duke University Medical Center, Durham
Pharmaceutical Research Associates Inc., Salt Lake City
CNS Healthcare, Orlando
Atlantic Shores Hospital, Lauderhill
Research Centers of America, Oakland Park
Neuro-Behavioral Clinical Research, Inc., Canton
Midwest Clinical Research Center, LLC, Dayton
Neuroscience Research Institute, Winfield
Insite Clinical Research, DeSoto
Baylor College of Medicine, Houston
Community Clinical Research, Inc., Austin
TRY Research, Maitland
North Country Clinical Research, Oceanside
NRC Research Institute, Orange
Comprehensive Clinical Research, Berlin
PRA Health Sciences, Marlton
Lead Sponsor
Alkermes, Inc.
INDUSTRY